The China-MSD HIV/AIDS Partnership (C-MAP) is a partnership between The Merck Company Foundation and China's Ministry of Health for the comprehensive prevention and treatment of HIV/AIDS in China. Established in 2005 with an initial five-year, US $30 million commitment from The Merck Company Foundation, the program is the most extensive HIV/AIDS prevention and treatment project to be conducted to date through collaboration between the Chinese government and a foreign company in China. First introduced in three counties in Liangshan Prefecture, Sichuan Province, C-MAP has been extended to another 20 regions and prefectures in Sichuan, reaching a total of 62 project sites. Learn more.
In 2010, Merck supported the Malaysian Society for HIV Medicine's "Reaching Out" program. The Reaching Out program is designed to help women, single mothers and injecting drug users (IDU) living with HIV/AIDS in need of psychosocial support and life skills. In 2011, MASHM will: (1) organize workshops for HIV caregivers that will provide updates on the utilization of new agents and their development for ID specialists focusing on both national and international guidelines; (2) will provide life-supporting skills and psychosocial support to women, pregnant women and single mothers living with HIV; and (3) will provide self-management support to injecting drug users on HAART regimens.